Rheumnow Podcast

JAK Inhibitors for New Indications

Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA

Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.

Treat to Target Outcomes in Early AxSpA

Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria.

Does Telemonitoring in SpA Work?

Dr. Antoni Chan reports on abstract OP0120 from Eular 2024 in Vienna, Austria.

PsA Treatment: is Earlier Better?

Dr. Aurelie Najm discusses abstract OP0184, presented at Eular 2024 in Vienna, Austria.

JAK Inhibitors for New Indications

Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Transition from Psoriasis to PsA: Can we Prevent It?

Dr. Aurelie Najm discusses abstract OP0010 presented at Eular 2024 in Vienna, Austria.

EULAR 2024 Daily Recap - Days 1 & 2

Moderated by Dr. Jack Cush and featuring Dr. Yuz Yusof and Dr. Mrinalini Dey

Mechanistic Promise in RA Doesn’t Always Mean Actual Gain

Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.

The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis

Dr. Mrinalini Dey reports from Eular 2024 in Vienna, Austria about an abstract she will present during the meeting, POS0309.